These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 27779286)

  • 1. [A study of cost-effectiveness of treating serious mental illness: challenges and solutions].
    Lokkerbol J; Nuijen J; Evers S; Knegtering H; Delespaul P; Kroon H; Bruggeman R
    Tijdschr Psychiatr; 2016; 58(10):700-705. PubMed ID: 27779286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
    Rothbard AB; Lee S; Blank MB
    J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare Costs for People with Serious Mental Illness in England: An Analysis of Costs Across Primary Care, Hospital Care, and Specialist Mental Healthcare.
    Ride J; Kasteridis P; Gutacker N; Aragon Aragon MJ; Jacobs R
    Appl Health Econ Health Policy; 2020 Apr; 18(2):177-188. PubMed ID: 31701484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing the access problem for patients with serious mental illness who require tertiary medical care.
    Hensel JM; Flint AJ
    J Health Care Poor Underserved; 2015 Feb; 26(1):35-48. PubMed ID: 25702725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of serious mental illness on health and healthcare.
    Viron MJ; Stern TA
    Psychosomatics; 2010; 51(6):458-65. PubMed ID: 21051676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of multiplicity of comorbid health conditions, serious mental illness, and health care costs.
    Lee S; Black D; Held M
    Soc Work Health Care; 2016 Aug; 55(7):518-30. PubMed ID: 27285200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring The Lifetime Costs Of Serious Mental Illness And The Mitigating Effects Of Educational Attainment.
    Seabury SA; Axeen S; Pauley G; Tysinger B; Schlosser D; Hernandez JB; Heun-Johnson H; Zhao H; Goldman DP
    Health Aff (Millwood); 2019 Apr; 38(4):652-659. PubMed ID: 30933598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of expanded mental health benefits on treatment costs.
    Sasso AT; Lurie IZ; Lee JU; Lindrooth RC
    J Ment Health Policy Econ; 2006 Mar; 9(1):25-33. PubMed ID: 16733269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inter-sectoral costs and benefits arising from mental health (disorders)].
    Paulus AT; Drost RM; Ruwaard D; Evers SM
    Tijdschr Psychiatr; 2016; 58(10):688-694. PubMed ID: 27779284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of treating mental illness from a managed care perspective.
    Docherty JP
    J Clin Psychiatry; 1999; 60 Suppl 3():49-52; discussion 53. PubMed ID: 10073378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mental health care system optimization from a health-economics perspective: where to sow and where to reap?
    Lokkerbol J; Weehuizen R; Mavranezouli I; Mihalopoulos C; Smit F
    J Ment Health Policy Econ; 2014 Jun; 17(2):51-60. PubMed ID: 25153093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cost-effectiveness in Dutch mental health care: future because of ROM?].
    van Agthoven M; van der Kolk A; Knegtering H; Delespaul PA; Arends J; Jeurissen PP; Krabbe PF; Huijsman R; Luijk R; De Beurs E; Hakkaart-Van Roijen L; Bruggeman R
    Tijdschr Psychiatr; 2015; 57(9):672-9. PubMed ID: 26401609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of managed behavorial healthcare on the costs of psychiatric and chemical dependency treatment.
    Geraty R; Bartlett J; Hill E; Lee F; Shusterman A; Waxman A
    Behav Healthc Tomorrow; 1994; 3(2):18-30. PubMed ID: 10172255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of psychotherapy for the major psychiatric diagnoses.
    Lazar SG
    Psychodyn Psychiatry; 2014 Sep; 42(3):423-57. PubMed ID: 25211432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost of mental disorders in France.
    Chevreul K; Prigent A; Bourmaud A; Leboyer M; Durand-Zaleski I
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):879-86. PubMed ID: 22959739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Operational Definition of Serious Mental Illness: Heterogeneity in a Review of the Research on Quality-of-Life Interventions.
    Martínez-Martínez C; Richart-Martínez M; Ramos-Pichardo JD
    J Am Psychiatr Nurses Assoc; 2020; 26(3):229-244. PubMed ID: 31999207
    [No Abstract]   [Full Text] [Related]  

  • 18. [Towards a sustainable, cost-effective mental health care; a policy perspective].
    Jeurissen PP; Ravesteijn BA; Janssen RT; Tanke MA
    Tijdschr Psychiatr; 2016; 58(10):683-687. PubMed ID: 27779283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of comorbid health conditions on healthcare expenditures among people with severe mental illness.
    Lee S; Rothbard A; Choi S
    J Ment Health; 2016 Aug; 25(4):291-296. PubMed ID: 26654582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence and correlates of untreated serious mental illness.
    Kessler RC; Berglund PA; Bruce ML; Koch JR; Laska EM; Leaf PJ; Manderscheid RW; Rosenheck RA; Walters EE; Wang PS
    Health Serv Res; 2001 Dec; 36(6 Pt 1):987-1007. PubMed ID: 11775672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.